These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21414671)

  • 41. Histamine receptors in the CNS as targets for therapeutic intervention.
    Passani MB; Blandina P
    Trends Pharmacol Sci; 2011 Apr; 32(4):242-9. PubMed ID: 21324537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Constitutive activity of the histamine H3 receptor.
    Arrang JM; Morisset S; Gbahou F
    Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High constitutive activity of native H3 receptors regulates histamine neurons in brain.
    Morisset S; Rouleau A; Ligneau X; Gbahou F; Tardivel-Lacombe J; Stark H; Schunack W; Ganellin CR; Schwartz JC; Arrang JM
    Nature; 2000 Dec; 408(6814):860-4. PubMed ID: 11130725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.
    Apodaca R; Dvorak CA; Xiao W; Barbier AJ; Boggs JD; Wilson SJ; Lovenberg TW; Carruthers NI
    J Med Chem; 2003 Aug; 46(18):3938-44. PubMed ID: 12930154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of human umbilical artery contractility by different serotonin and histamine receptors.
    Santos-Silva AJ; Cairrão E; Marques B; Verde I
    Reprod Sci; 2009 Dec; 16(12):1175-85. PubMed ID: 19801536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
    Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
    J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs.
    Strasser A; Wittmann HJ; Buschauer A; Schneider EH; Seifert R
    Trends Pharmacol Sci; 2013 Jan; 34(1):13-32. PubMed ID: 23228711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a homogeneous binding assay for histamine receptors.
    Crane K; Shih DT
    Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological properties of histamine receptor subtypes.
    Arrang JM
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
    Panetta R; Greenwood MT
    Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine receptor subtypes: a century of rational drug design.
    Walter M; Stark H
    Front Biosci (Schol Ed); 2012 Jan; 4(2):461-88. PubMed ID: 22202071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.
    Sander K; Kottke T; Proschak E; Tanrikulu Y; Schneider EH; Seifert R; Schneider G; Stark H
    Inflamm Res; 2010 Mar; 59 Suppl 2():S249-51. PubMed ID: 20012148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
    Panula P; Chazot PL; Cowart M; Gutzmer R; Leurs R; Liu WL; Stark H; Thurmond RL; Haas HL
    Pharmacol Rev; 2015 Jul; 67(3):601-55. PubMed ID: 26084539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.